R&D Partner Content Less than three weeks away: Join Global Experts at Transderm... 11-12 November 2024 in London, UK
Events Partner Content Transdermal and Microneedle Drug Delivery 2023 Transdermal and Microneedle Drug Delivery 2023
Events Partner Content Transdermal and Microneedle Drug Delivery Latest innovations in drug delivery beyond the needle
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
